Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (41-50 of 536) with videos related to

Pageof 54
Sort By:
Rapid Communications in Mass Spectrometry : RCM|April 3, 2003
Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the bloodJim J Xiao, John Byrd, Guido Marcucci, et al.
Blood|September 9, 2006
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Krzysztof Mrózek, Guido Marcucci, Peter Paschka, et al.
Leukemia Research|August 5, 2019
The feasibility of venetoclax and decitabine in therapy-related acute myeloid leukemia with concurrent advanced non-hematological malignanciesSalman Otoukesh, Amandeep Salhotra, Guido Marcucci, et al.
Best Practice & Research. Clinical Haematology|August 25, 2009
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemiasGuido Marcucci, Krzysztof Mrózek, Michael D Radmacher, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 23, 2005
Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometryGuowei Dai, Xiaohui Wei, Zhongfa Liu, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|March 12, 2002
Leukocytoreduction for acute leukemiaPierluigi Porcu, Sherif Farag, Guido Marcucci, et al.
The Journal of Clinical Investigation|February 16, 2016
Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cellsBin Zhang, Ling Li, Yinwei Ho, et al.
Rapid Communications in Mass Spectrometry : RCM|March 9, 2006
Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification methodZhongfa Liu, Guido Marcucci, John C Byrd, et al.
Research Square|January 30, 2023
Human ILC1s target leukemia stem cells and control development of AMLMichael Caligiuri, Zhenlong Li, Rui Ma, et al.
American Journal of Hematology|April 28, 2021
Refractory primary autoimmune myelofibrosis treated with ruxolitinibSalman Otoukesh, Joo Y Song, Mona Mojtahedzadeh, et al.
Pageof 54

Showing results (41-50 of 536) with videos related to

Sort By:
Pageof 54
Rapid Communications in Mass Spectrometry : RCM|April 3, 2003
Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the bloodJim J Xiao, John Byrd, Guido Marcucci, et al.
Blood|September 9, 2006
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Krzysztof Mrózek, Guido Marcucci, Peter Paschka, et al.
Leukemia Research|August 5, 2019
The feasibility of venetoclax and decitabine in therapy-related acute myeloid leukemia with concurrent advanced non-hematological malignanciesSalman Otoukesh, Amandeep Salhotra, Guido Marcucci, et al.
Best Practice & Research. Clinical Haematology|August 25, 2009
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemiasGuido Marcucci, Krzysztof Mrózek, Michael D Radmacher, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 23, 2005
Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometryGuowei Dai, Xiaohui Wei, Zhongfa Liu, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|March 12, 2002
Leukocytoreduction for acute leukemiaPierluigi Porcu, Sherif Farag, Guido Marcucci, et al.
The Journal of Clinical Investigation|February 16, 2016
Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cellsBin Zhang, Ling Li, Yinwei Ho, et al.
Rapid Communications in Mass Spectrometry : RCM|March 9, 2006
Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification methodZhongfa Liu, Guido Marcucci, John C Byrd, et al.
Research Square|January 30, 2023
Human ILC1s target leukemia stem cells and control development of AMLMichael Caligiuri, Zhenlong Li, Rui Ma, et al.
American Journal of Hematology|April 28, 2021
Refractory primary autoimmune myelofibrosis treated with ruxolitinibSalman Otoukesh, Joo Y Song, Mona Mojtahedzadeh, et al.
Pageof 54